Second generation instis for the treatment of HIV-1 in patients with TB CO-infection on rifampicin-based treatment in kwazulu natal, south africa

Ended Project Grant Awarded Last action

Award ID
R01AI152142
Recipient
Awarding agency
Obligated
$5,011,506

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Funding
  • $4,819,013.00 Federal
  • $192,493.00 Non-federal
Place of performance
South Africa

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $285,787 $0
Amendment $200,932 $0
Amendment $290,914 $0
Amendment $282,070 $0
Amendment $282,070 $0
Amendment $369,940 $0
Amendment $369,940 $0
Amendment $303,515 $0
Amendment $303,515 $0
Amendment $303,515 $0
Amendment $129,848 $0
Amendment $129,848 $0
Amendment $129,848 $0
Amendment $129,848 $0
Amendment $192,499 $0
Amendment $122,912 $0
Amendment $122,912 $0
Amendment $192,493 $0
Amendment $137,534 $0
Amendment $192,493 $192,493
Amendment $154,093 $0
Original award $192,487 $0
Show all 23

Quick answers

Who received award R01AI152142?

R01AI152142 was awarded to Centre For The Aids Program Of Research In South Africa by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 3, 2020.

How much is award R01AI152142 worth?

$5,011,506 has been obligated on R01AI152142: $4,819,013 in federal funding and $192,493 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award